UnitedHealth Group Inc (UNH) Expected to Post Earnings of $2.38 Per Share

UnitedHealth Group Inc (UNH) Expected to Post Earnings of $2.38 Per Share

Equities analysts predict that UnitedHealth Group Inc (NYSE:UNH) will announce earnings per share of $2.38 for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for UnitedHealth Group’s earnings, with the highest EPS estimate coming in at $2.41 and the lowest estimate coming in at $2.35. UnitedHealth Group posted earnings per share of $1.96 in the same quarter last year, which indicates a positive year-over-year growth rate of 21.4%. The business is expected to announce its next earnings results on Tuesday, July 18th.

According to Zacks, analysts expect that UnitedHealth Group will report full year earnings of $9.80 per share for the current fiscal year, with EPS estimates ranging from $9.75 to $9.85. For the next financial year, analysts anticipate that the company will post earnings of $10.75 per share, with EPS estimates ranging from $10.67 to $11.00. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that that provide coverage for UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.17 by $0.20. The firm earned $48.72 billion during the quarter, compared to analysts’ expectations of $48.21 billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The firm’s revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.81 earnings per share. Several research analysts have recently commented on the company. Vetr lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 target price for the company. in a research report on Monday, April 24th. Deutsche Bank AG reiterated a “buy” rating and issued a $187.00 target price (up previously from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Jefferies Group LLC reiterated a “buy” rating and issued a $192.00 target price (up previously from $186.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $205.00 target price (up previously from $200.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Finally, Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $187.00 price target (up previously from $186.00) on shares of UnitedHealth Group in a report on Friday, April 21st. Two investment analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $182.65.

UnitedHealth Group (NYSE:UNH) traded up 0.86% during midday trading on Monday, reaching $174.02. The company had a trading volume of 2,585,202 shares. The firm has a market capitalization of $169.67 billion, a PE ratio of 22.28 and a beta of 0.68. The firm’s 50-day moving average price is $168.47 and its 200 day moving average price is $160.07. UnitedHealth Group has a 12 month low of $128.53 and a 12 month high of $176.14. In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Tuesday, February 14th. The stock was sold at an average price of $162.68, for a total transaction of $813,400.00. Following the transaction, the director now directly owns 75,391 shares in the company, valued at approximately $12,264,607.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP D Ellen Wilson sold 14,000 shares of UnitedHealth Group stock in a transaction on Wednesday, April 19th. The shares were sold at an average price of $170.54, for a total value of $2,387,560.00. Following the transaction, the executive vice president now owns 31,993 shares in the company, valued at $5,456,086.22. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,148 shares of company stock worth $7,620,249. 1.65% of the stock is owned by insiders.

Several institutional investors have recently modified their holdings of UNH. Conning Inc. boosted its position in shares of UnitedHealth Group by 0.4% in the third quarter. Conning Inc. now owns 36,075 shares of the healthcare conglomerate’s stock valued at $5,051,000 after buying an additional 160 shares during the period. HL Financial Services LLC boosted its position in shares of UnitedHealth Group by 1.9% in the third quarter. HL Financial Services LLC now owns 13,147 shares of the healthcare conglomerate’s stock valued at $1,841,000 after buying an additional 242 shares during the period. Joel Isaacson & Co. LLC boosted its position in shares of UnitedHealth Group by 4.2% in the third quarter. Joel Isaacson & Co. LLC now owns 3,358 shares of the healthcare conglomerate’s stock valued at $470,000 after buying an additional 136 shares during the period. Commonwealth Equity Services Inc boosted its position in shares of UnitedHealth Group by 0.4% in the third quarter. Commonwealth Equity Services Inc now owns 116,741 shares of the healthcare conglomerate’s stock valued at $16,344,000 after buying an additional 483 shares during the period. Finally, BTC Capital Management Inc. purchased a new position in shares of UnitedHealth Group during the third quarter valued at about $1,963,000. Institutional investors own 86.67% of the company’s stock. About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com Receive News & Ratings for UnitedHealth Group Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment